Yiye Zhang1, Rema Padman. 1. The H. John Heinz III College, Carnegie Mellon University, 4800 Forbes Ave, Pittsburgh, PA 15213. E-mail: yiyez@andrew.cmu.edu.
Abstract
OBJECTIVES: Chronic diseases are common, complex, and expensive health conditions that can benefit from innovations in healthcare service delivery enabled by information technology and advanced analytic methods. This paper proposes a data-driven approach, illustrated in the context of chronic kidney disease (CKD), to develop clinical pathways of care delivery from electronic health record (EHR) data. STUDY DESIGN: We analyzed structured and de-identified EHR data from 2009 to 2013 of 664 CKD patients with multiple chronic conditions. METHODS: Machine learning algorithms were used to learn data-driven and practice-based clinical pathways that cluster patients into subgroups and model the co-progression of their encounter types, diagnoses, medications, and biochemical measurements. Given a pattern of biochemical measurements, our algorithm identifies the most probable clinical pathways, and makes predictions regarding future states, with and without temporal information. CKD stages, their complications, and common medications are included in the clinical pathways. RESULTS: Using the EHR data of 664 patients who were initially in CKD stage 3 and hypertensive, we identified 7 patient subgroups-each distinguished primarily by the type of complications suffered by the patients. Our algorithm demonstrates fair accuracy (up to 44% and 75%, respectively) in learning the most probable clinical pathways and predicting future states associated with temporal patterns of biochemical measurements and patient subgroups. CONCLUSIONS: Data-driven clinical pathway learning summarizes multidimensional and longitudinal information from EHRs into clusters of common sequences of patient visits that may assist in the efficient review of current practices and identifying potential innovations in the care delivery process.
OBJECTIVES:Chronic diseases are common, complex, and expensive health conditions that can benefit from innovations in healthcare service delivery enabled by information technology and advanced analytic methods. This paper proposes a data-driven approach, illustrated in the context of chronic kidney disease (CKD), to develop clinical pathways of care delivery from electronic health record (EHR) data. STUDY DESIGN: We analyzed structured and de-identified EHR data from 2009 to 2013 of 664 CKDpatients with multiple chronic conditions. METHODS: Machine learning algorithms were used to learn data-driven and practice-based clinical pathways that cluster patients into subgroups and model the co-progression of their encounter types, diagnoses, medications, and biochemical measurements. Given a pattern of biochemical measurements, our algorithm identifies the most probable clinical pathways, and makes predictions regarding future states, with and without temporal information. CKD stages, their complications, and common medications are included in the clinical pathways. RESULTS: Using the EHR data of 664 patients who were initially in CKD stage 3 and hypertensive, we identified 7 patient subgroups-each distinguished primarily by the type of complications suffered by the patients. Our algorithm demonstrates fair accuracy (up to 44% and 75%, respectively) in learning the most probable clinical pathways and predicting future states associated with temporal patterns of biochemical measurements and patient subgroups. CONCLUSIONS: Data-driven clinical pathway learning summarizes multidimensional and longitudinal information from EHRs into clusters of common sequences of patient visits that may assist in the efficient review of current practices and identifying potential innovations in the care delivery process.
Authors: Abhijit V Kshirsagar; Daniel E Weiner; Mallika L Mendu; Frank Liu; Susie Q Lew; Terrence J O'Neil; Scott D Bieber; David L White; Jonathan Zimmerman; Sumit Mohan Journal: Clin J Am Soc Nephrol Date: 2022-03-14 Impact factor: 10.614
Authors: Tony Rosen; Yuhua Bao; Yiye Zhang; Sunday Clark; Katherine Wen; Alyssa Elman; Philip Jeng; Elizabeth Bloemen; Daniel Lindberg; Richard Krugman; Jacquelyn Campbell; Ronet Bachman; Terry Fulmer; Karl Pillemer; Mark Lachs Journal: BMJ Open Date: 2021-02-05 Impact factor: 2.692
Authors: Luiza Siqueira do Prado; Samuel Allemann; Marie Viprey; Anne-Marie Schott; Dan Dediu; Alexandra L Dima Journal: BMJ Open Date: 2020-03-18 Impact factor: 2.692